BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mazzanti R, Messerini L, Comin CE, Fedeli L, Gannè-Carrie N, Beaugrand M. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. World J Gastroenterol 2007; 13(37): 5009-5014 [PMID: 17854145 DOI: 10.3748/wjg.v13.i37.5009]
URL: https://www.wjgnet.com/1007-9327/full/v13/i37/5009.htm
Number Citing Articles
1
Fabrice Muscari, Bertrand Foppa, Nicolas Carrere, Nassim Kamar, Jean‐Marie Peron, Bertrand Suc. Resection of a Transplantable Single‐Nodule Hepatocellular Carcinoma in Child‐Pugh Class A Cirrhosis: Factors Affecting Survival and RecurrenceWorld Journal of Surgery 2011; 35(5): 1055 doi: 10.1007/s00268-011-1000-3
2
Domenico Ribatti, Anna Sandra Belloni, Beatrice Nico, Mariasevera Di Comite, Enrico Crivellato, Angelo Vacca. Leptin–leptin receptor are involved in angiogenesis in human hepatocellular carcinomaPeptides 2008; 29(9): 1596 doi: 10.1016/j.peptides.2008.05.011
3
Wei-Dong Jia, Ge-Liang Xu, Wei Wang, Zhi-Hua Wang, Jian-Sheng Li, Jin-Liang Ma, Wei-Hua Ren, Yong-Sheng Ge, Ji-Hai Yu, Wen-Bin Liu. A Somatostatin Analogue, Octreotide, Inhibits the Occurrence of Second Primary Tumors and Lung Metastasis after Resection of Hepatocellular Carcinoma in MiceThe Tohoku Journal of Experimental Medicine 2009; 218(2): 155 doi: 10.1620/tjem.218.155
4
Gülsüm Özlem Elpek. Angiogenesis and liver fibrosisWorld Journal of Hepatology 2015; 7(3): 377-391 doi: 10.4254/wjh.v7.i3.377
5
Roberto Mazzanti, Laura Gramantieri, Luigi Bolondi. Hepatocellular carcinoma: Epidemiology and clinical aspectsMolecular Aspects of Medicine 2008; 29(1-2): 130 doi: 10.1016/j.mam.2007.09.008
6
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
7
Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo. Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus InfectionClinical Gastroenterology and Hepatology 2010; 8(11): 924 doi: 10.1016/j.cgh.2010.06.032
8
Mohamed A. Abdel Mohsen, Neveen A. Hussein, Abeer A. Ghazal, Marwa K. El-Ghandour, Mohamed Farouk, Abeer E. Abd El-Wahab, Amany I. Yousef. Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinomaAlexandria Journal of Medicine 2014; 50(3): 235 doi: 10.1016/j.ajme.2014.06.003
9
Fidel D. Huitzil‐Melendez, Ghassan K. Abou‐Alfa, Michael A. Morse. Malignant Liver Tumors2010; : 382 doi: 10.1002/9781444317053.ch32
10
Gisèle Nkontchou, Mounir Aout, Amel Mahmoudi, Dominique Roulot, Valérie Bourcier, Véronique Grando-Lemaire, Nathalie Ganne-Carrie, Jean-Claude Trinchet, Eric Vicaut, Michel Beaugrand. Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated CirrhosisCancer Prevention Research 2012; 5(8): 1007 doi: 10.1158/1940-6207.CAPR-11-0450
11
Bin Zhu, Jun-Jie Chen, Ying Feng, Jun-Ling Yang, Hua Huang, Wen Yuan Chung, Yi-Lin Hu, Wan-Jiang Xue. DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02110-6